share_log

HC Wainwright & Co. Reiterates Buy on Biotricity, Maintains $2 Price Target

Benzinga Real-time News ·  Feb 15, 2023 19:06

HC Wainwright & Co. analyst Kevin Dede reiterates Biotricity (NASDAQ:BTCY) with a Buy and maintains $2 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment